axicabtagene ciloleucel,cyclophosphamide,fludarabine
gilead
['lymsm', 'zuma-7', 'axicel', 'axi-cel']
zuma-7 os update #17icml:
- 359 pts (most pts got car in axicel arm, only 1/3 got asct in soc arm)
- significant improvement in os despite 57% of pts getting off protocol axi-cel in soc arm
earlier car for high risk primary refractory or early relapse appears to be better! #lymsm 
Lymphoma doc & patient-reported outcomes researcher in #lymsm and #mmsm @CUHematology. Founder of https://t.co/kN6qeGFEox, @inTrainingDoc & @inHouseMag. 🏳️‍🌈